SIMPONI (golimumab) Patient Assistance Program
Don’t let the high cost of Simponi or Simponi Aria disrupt your treatment. The Johnson & Johnson Patient Assistance Program provides golimumab free of charge to eligible patients — and we manage your entire enrollment for a flat $69.95 per month.
- Clear & Transparent Pricing
- Paperwork, Documentation & Doctor-Coordination Handled For You
- Comprehensive Support: From Application to Entire Journey.
- Annual Re-Certification And Refills Management
- Guidance For Both Simponi (Self-Injected, Part D) And Simponi Aria (Infused, Part B)
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Simponi (Golimumab) Is FDA-Approved For Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis, And Ulcerative Colitis. It Is A TNF-Blocker With A Convenience Advantage: One Self-Injection Per Month. Simponi Aria Is The IV-Infused Version Given Every 8 Weeks.
- Without Assistance, Simponi’s Cash Price Runs Roughly $6,500 Per Monthly 50 mg Injection. The Johnson & Johnson Patient Assistance Program Provides Free Medication For Up To One Year To Patients With Household Income Up To 400% Of The Federal Poverty Level — About $128,600 For A Family Of Four.
- Commercially Insured Patients Pay As Little As $5 Per Injection (Or Per Infusion) Through The J&J withMe Savings Program — With A Separate Rebate Program For Simponi Aria Infusion-Administration Fees.
- The First Golimumab Biosimilars (Immgolis) Were FDA-Approved In May 2026 But Are Not Yet On The Market Due To Patent Litigation — For Now, Assistance Programs Remain The Realistic Path To Affordability.
What Is Simponi Prescription Assistance Program?
The Simponi Patient Assistance Program is run by the Johnson & Johnson Patient Assistance Program and provides Simponi — and Simponi Aria — free of charge to qualifying patients for up to one year, with annual re-verification. Eligibility reaches household incomes up to 400% of the Federal Poverty Level (around $128,600 for a family of four, plus $22,000 per additional person), and the program serves not only the uninsured but also patients whose commercial or government coverage doesn’t fully meet their needs. Applying directly (833-742-0791, Mon–Fri 8 AM–8 PM ET) is always free. The hard part is everything around the form — eligibility verification, income documentation, rheumatology or GI coordination, prior-authorization records, denial appeals, renewal deadlines — plus a wrinkle specific to golimumab: Simponi and Simponi Aria are billed completely differently (pharmacy benefit vs. infused Part B), and picking the wrong support program for your version wastes months. For a flat $69.95 per month, our Patient Advocates handle every step and route you to the right program the first time.
Pharmacy Price Comparison
- Without assistance, brand Simponi costs roughly $6,500–$7,800 per monthly dose. A Patient Assistance Program is the meaningful path forward — if you qualify:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens | ~$7,500.00 | Save ~$7,430/mo |
| CVS Pharmacy | ~$7,800.00 | Save ~$7,730/mo |
| Walmart | ~$7,000.00 | Save ~$6,930/mo |
| Costco | ~$6,700.00 | Save ~$6,630/mo |
| Specialty Pharmacy | ~$6,800.00 | Save ~$6,730/mo |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Simponi Prescription Program?
The J&J Patient Assistance Program is free to apply for and provides golimumab at no medication cost if approved. Our $69.95/month service covers full advocacy — for patients who want an experienced team managing the process end-to-end, especially when choosing between Simponi and Simponi Aria support routes.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Simponi:
Limitations of Coupons
- Prices fluctuate — savings aren’t guaranteed month-to-month
- Copay accumulators may prevent savings from counting toward deductible
- Coupon cards expire and require constant renewal
- Still $6,500–$7,800 per month even with the best discount
- Can’t be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
- Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
- Medication supplied directly through the assistance program
- We manage all paperwork, refills, and annual renewals
- If denied, we explore alternative savings on your behalf
DO YOU QUALIFY?
The Johnson & Johnson Patient Assistance Program publishes clear eligibility rules for free Simponi. You will generally qualify if all of the following are true — and if your situation doesn’t fit neatly, contact AffordMyPrescriptions so we can review your case and determine if you qualify for Simponi assistance:
- You Are A U.S. Citizen Or Legal Resident
- You Have A Valid Simponi Or Simponi Aria Prescription From A Licensed U.S. Healthcare Provider
- You Are Uninsured — Or Your Commercial Or Government Coverage Does Not Fully Meet Your Needs
- Your Household Income Is At Or Below 400% Of The Federal Poverty Level (About $128,600 For A Family Of Four)
Not sure if you qualify? Our pre-qualification check is completely free. If we can’t help, you won’t be charged.
Understanding Simponi:
Simponi (golimumab) is a human monoclonal antibody that binds and neutralizes tumor necrosis factor alpha (TNF-α), the inflammatory protein that drives joint destruction in rheumatoid and psoriatic arthritis, spinal inflammation in ankylosing spondylitis, and mucosal damage in ulcerative colitis.
How Simponi Works:
In TNF-driven autoimmune disease, excess TNF-α keeps immune cells in a state of chronic attack against joints, spine, and gut. Simponi binds both soluble and membrane-bound TNF, blocking it from activating its receptors and interrupting the inflammatory cascade. Its distinguishing practical feature among TNF blockers is dosing convenience: one subcutaneous injection per month, versus weekly (Enbrel) or biweekly (Humira) schedules.
Form and Use:
Simponi is self-injected monthly — 50 mg for rheumatologic indications, 100 mg for ulcerative colitis — via the SmartJect autoinjector or prefilled syringe. Simponi Aria is the intravenous version, weight-based at 2 mg/kg, infused at weeks 0 and 4 and then every 8 weeks in a clinic. The choice between them isn’t just clinical: it flips your billing from the pharmacy benefit (Part D for Medicare) to the medical benefit (Part B), which changes your costs, your assistance options, and your paperwork — one of the most common things we untangle for patients.
Biosimilar Availability:
The first golimumab biosimilars — Immgolis and Immgolis Intri — were FDA-approved in May 2026, but neither is on the U.S. market yet: patent litigation filed by Janssen is pending, with launch timing uncertain. Until a biosimilar actually ships, there is no lower-priced golimumab; other TNF blockers with biosimilars (like adalimumab) are different drugs requiring a treatment change, not a substitution.
Warnings:
Simponi carries a boxed warning for serious infections — including tuberculosis and invasive fungal infections — and for lymphoma and other malignancies. Patients should be TB-tested before starting, avoid live vaccines during treatment, and promptly report fevers, persistent cough, or unusual bruising. Tell your prescriber about any history of heart failure, hepatitis B, or demyelinating disease.
FAQ (Frequently Asked Questions)
How Much Does Simponi Cost Without Insurance?
Cash prices run roughly $6,500 per monthly 50 mg injection — around $78,000 per year. Eligible patients can receive Simponi free through the Johnson & Johnson Patient Assistance Program; our $69.95 monthly fee covers full advocacy and enrollment management.
What’s The Difference Between Simponi And Simponi Aria?
Same active drug, different delivery: Simponi is a once-monthly self-injection billed through your pharmacy benefit; Simponi Aria is an IV infusion every 8 weeks billed through your medical benefit (Medicare Part B). The cost structures, assistance programs, and paperwork differ completely — which is why we confirm your version before recommending a program
Does Medicare Cover Simponi?
Yes — self-injected Simponi under Part D, where the $2,100 annual out-of-pocket cap (2026) applies; Simponi Aria under Part B, where you owe 20% coinsurance and the cap does not apply. That asymmetry means the affordable route for a Medicare patient can depend on which version they’re on — worth a conversation with both your prescriber and our advocates.
Can I Use The withMe $5 Program With Medicare?
No — it’s restricted to commercially insured patients. Medicare patients rely on the Part D cap (Simponi), supplemental coverage (Aria), Extra Help if income-qualified, or the free-drug program if eligible.
Is There A Generic Or Biosimilar For Simponi?
FDA approved the first golimumab biosimilars (Immgolis) in May 2026, but patent litigation has kept them off the market so far. No biosimilar golimumab is available to patients as of now
How Long Does Program Approval Last?
Up to one year, with annual re-verification. We track your renewal date and re-file before coverage lapses — important for a drug where one missed monthly dose is a meaningful treatment gap.
Take Control of Your Medication Costs
J&J’s assistance program reaches higher incomes than most patients assume — up to 400% of the poverty level — and the $5 withMe program covers both versions of golimumab. Check your eligibility today; the pre-qualification review is free, and if we can’t help you, you pay nothing.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.